In vitro activities of garenoxacin (BMS-284756) against 170 clinical isolates of nine Pasteurella species |
| |
| Authors: | Goldstein Ellie J C Citron Diane M Merriam C Vreni Warren Yumi A Tyrrell Kerin L Fernandez Helen T |
| |
| Affiliation: | R. M. Alden Research Laboratory, Santa Monica-University of California, Los Angeles, Medical Center, Santa Monica, California 90404, USA. EJCGMD@aol.com |
| |
| Abstract: | The in vitro susceptibilities of 170 clinical isolates plus 12 American Type Culture Collection strains of Pasteurella species comprising nine species and three Pasteurella multocida subspecies were studied by an agar dilution method. Garenoxacin (BMS-284756), a new des-fluoro(6) quinolone, was active at 90% of the strains susceptible to
|
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
